Cadila Healthcare informs about press release

05 Oct 2018 Evaluate

Cadila Healthcare has informed about press release titled ‘Zydus receives final approval from the USFDA for Exemestane Tablets’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

886.75 -6.70 (-0.75%)
28-Jan-2026 10:13 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.20
Dr. Reddys Lab 1230.10
Cipla 1321.50
Zydus Lifesciences 886.75
Lupin 2129.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×